Did we ever figure out why that highly decorated academic guy took a job at a company that has a crappy drug? I can't be the first one to think that it would be easy for big pharma to torpedo the bavi threat from the inside, right?
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.